Health Protection Scotland (HPS), NHS National Services Scotland, Glasgow, United Kingdom.
Euro Surveill. 2013 Sep 26;18(39):20593. doi: 10.2807/1560-7917.es2013.18.39.20593.
In September 2008, Scotland introduced a national human papillomavirus (HPV) immunisation programme with bivalent HPV vaccine, to prevent cervical cancer. This school-based programme routinely vaccinates girls aged between 12 and 13 years. A catch-up campaign, running over three years, also began at this time, offering vaccination to all girls aged 13 years to under 18 years old. The HPV immunisation campaign presented challenges due to this vaccine being targeted to girls in school and older girls who had left school. Following a long and comprehensive planning process, this campaign was successfully implemented across Scotland, delivering high vaccine uptake of 91.4% for three doses of vaccine in the first year (September 2008 to August 2009) for the routine cohort and 90.1% in the second year (September 2009 to August 2010) for the routine cohort. We describe the planning process, challenges and implementation strategies employed to achieve this high uptake.
2008 年 9 月，苏格兰推出了一项全国性的人乳头瘤病毒（HPV）免疫计划，使用二价 HPV 疫苗预防宫颈癌。该基于学校的计划常规为 12 至 13 岁的女孩接种疫苗。同时，一场为期三年的补种运动也在此时开始，为所有 13 岁至 18 岁的女孩提供疫苗接种。由于这种疫苗针对在校女孩和已经离开学校的大龄女孩，HPV 免疫接种活动带来了挑战。经过漫长而全面的规划过程，该活动在苏格兰各地成功实施，常规队列中第一年（2008 年 9 月至 2009 年 8 月）有 91.4%的女孩接种了三剂疫苗，第二年（2009 年 9 月至 2010 年 8 月）有 90.1%的女孩接种了三剂疫苗。我们描述了为实现这一高接种率而采用的规划流程、挑战和实施策略。
